New Paradigms and Innovations in Congestive Heart Failure and Atrial Fibrillation-Slides

Slides

Pdf Summary

This presentation by Dr. Ebrahim Barkoudah focuses on new paradigms and innovations in the management of congestive heart failure (HF) and atrial fibrillation (AF) from a hospital medicine perspective. Key goals include understanding recent research, mastering updated treatment strategies, and enhancing patient-centered care during hospitalization. The talk emphasizes adherence to current guidelines rather than brand names or trial specifics, the importance of focusing on the hospital course, and minimizing subgroup analyses post-trials.<br /><br />The epidemiology of HF and AF hospitalizations highlights increasing burdens, with AF prevalence rising among HF patients, complicating management and outcomes. Updated guidelines from major bodies such as the ESC, ACC/AHA, and CCS are reviewed, including the 2021 ESC and 2022 AHA/ACC/HFSA guidelines, which incorporate novel pharmacotherapies and refined diagnostic and treatment criteria.<br /><br />A significant barrier addressed is clinical inertia—the failure to initiate or intensify guideline-directed medical therapy (GDMT) during hospitalization and after discharge. Causes include patient factors (comorbidities, frailty, adherence challenges), treatment issues (intolerance, side effects), and healthcare system factors (cost, accessibility). Overcoming inertia requires education, patient empowerment, performance monitoring, and integrating new technologies like AI and telemedicine to promote personalized and value-based care.<br /><br />The hospitalization phase is viewed as a critical opportunity to optimize therapies, reassess diagnostics, and plan safe discharge and follow-up to improve outcomes. Approaches involve early diuresis, stabilization, medication optimization, and stratification of care needs.<br /><br />For AF management during hospitalization, rate control remains generally preferred, with rhythm control reserved for specific scenarios such as reversible causes or refractory symptoms. Optimal heart rate targets are debated, emphasizing individualized care.<br /><br />Overall, the presentation advocates addressing treatment gaps via guideline adherence, leveraging hospital admissions as pivotal intervention points, and employing multi-faceted strategies to improve long-term heart failure and atrial fibrillation outcomes.

Keywords

congestive heart failure

atrial fibrillation

hospital medicine

guideline-directed medical therapy

clinical inertia

ESC guidelines

AHA/ACC/HFSA guidelines

hospitalization management

patient-centered care

pharmacotherapy innovations